Project Grant R01AI185544
Award Date
7/17/25
Completion Date
6/30/30
Dollars Obligated
$881K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pensilvania, EE. UU.
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $395,496 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, San Francisco. The grant supports a study using metagenomic next-generation sequencing (MNGS) to provide novel insights into pathogen transmission and antimicrobial resistance acquisition in neonatal intensive care units (NICUs). The research aims to: 1) identify nosocomial transmission...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $128,655 to the University of Pittsburgh to enhance surveillance methods for genomic epidemiology in healthcare. The project aims to test the hypothesis that combining real-time whole genome sequencing (WGS) surveillance of bacterial pathogens with targeted environmental cultures will improve identification and control...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $820,623.00 to The Children's Hospital of Philadelphia (CHOP) to conduct research on the genetic determinants of SPI1 expression and activity in human germinal center B cells. The research aims to: 1) Identify non-coding elements regulating SPI1 gene expression in human germinal center B cells; 2) Delineate effects of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), supports research to develop real-time detection methods for Staphylococcus aureus transmission in hospital settings. The $3,210,845 award to New York University aims to integrate whole-genome sequencing with weekly colonization sampling to analyze transmission dynamics and create predictive models that can...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $445,000.00 to The Children's Hospital of Philadelphia (CHOP) to develop technologies for delineating haplotype-resolved, full-length transcriptomes in bulk tissues and single cells. The project aims to characterize transcript isoforms of haploinsufficient genes to discover novel therapeutic targets, as well as establish a program for...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $401,191 to The Johns Hopkins University to characterize the neonatal nasal microbiome following a parent-to-child nasal microbiota transplant. The goal is to determine whether bacteria from the parent's anterior nares can be transferred to and seed the neonate's nares, engraft in the neonatal microbiome,...
This federal Project Grant award of $2,442,535 was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The goal of this 5-year project is to provide critically-needed evidence on how to implement newborn genomic sequencing, manage findings, and reanalyze data to ensure it provides lifelong benefits to individuals and advances public health. The key...
This $534,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to develop wastewater surveillance systems for monitoring multidrug-resistant bacteria (MDRB). The key objectives are to: Establish standardized wastewater surveillance strategies to inform clinical infection control responses, using long-read metagenomics and novel bioinformatics to rapidly identify significant changes in...
This Project Grant award of $781,129 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a 5-year study to validate and extend an integrated host-microbe (IHM) diagnostic approach for accurately diagnosing lower respiratory tract infections (LRTIs) in critically ill children. The study aims to: 1) validate the performance of the existing IHM LRTI diagnostic classifier, 2) develop a novel host gene expression...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research provides $259,461 to The Methodist Hospital Research Institute to investigate the genomic factors and clinical impact associated with non-carbapenemase producing carbapenem-resistant Klebsiella pneumoniae (NCP-KPN) infections. The key objectives are to characterize a large international collection of NCP-KPN isolates using whole genome...